161 related articles for article (PubMed ID: 27398803)
21. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
22. Post-transplant malignancy: a burdensome complication in renal allograft recipients in Korea.
Kim JH; Kim SO; Han DJ; Park SK
Clin Transplant; 2014 Apr; 28(4):434-42. PubMed ID: 24750289
[TBL] [Abstract][Full Text] [Related]
23. Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndrome.
van Kruijsdijk RC; van der Graaf Y; Peeters PH; Visseren FL;
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1267-77. PubMed ID: 23677576
[TBL] [Abstract][Full Text] [Related]
24. Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014.
Taborelli M; Piselli P; Ettorre GM; Lauro A; Galatioto L; Baccarani U; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Sforza D; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Burra P; Rossi M; Tisone G; Zamboni F; Serraino D;
Int J Cancer; 2018 Oct; 143(7):1588-1594. PubMed ID: 29693248
[TBL] [Abstract][Full Text] [Related]
25. Risk of cancer in patients with irritable bowel syndrome: a nationwide population-based study.
Hu LY; Ku FC; Lu T; Shen CC; Hu YW; Yeh CM; Tzeng CH; Chen TJ; Chen PM; Liu CJ
Ann Epidemiol; 2015 Dec; 25(12):924-8. PubMed ID: 26507852
[TBL] [Abstract][Full Text] [Related]
26. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.
Butler AM; Olshan AF; Kshirsagar AV; Edwards JK; Nielsen ME; Wheeler SB; Brookhart MA
Am J Kidney Dis; 2015 May; 65(5):763-72. PubMed ID: 25662835
[TBL] [Abstract][Full Text] [Related]
27. Associations between ocular melanoma and other primary cancers: an international population-based study.
Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
[TBL] [Abstract][Full Text] [Related]
28. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
29. Post-transplant malignancy in liver transplantation: a single center experience.
Hsiao CY; Lee PH; Ho CM; Wu YM; Ho MC; Hu RH
Medicine (Baltimore); 2014 Dec; 93(28):e310. PubMed ID: 25526480
[TBL] [Abstract][Full Text] [Related]
30. Pre-transplant predictors of cerebrovascular events after kidney transplantation.
Aull-Watschinger S; Konstantin H; Demetriou D; Schillinger M; Habicht A; Hörl WH; Watschinger B
Nephrol Dial Transplant; 2008 Apr; 23(4):1429-35. PubMed ID: 18045824
[TBL] [Abstract][Full Text] [Related]
31. The risk of thromboembolic events in kidney transplant patients.
Verhave JC; Tagalakis V; Suissa S; Madore F; Hébert MJ; Cardinal H
Kidney Int; 2014 Jun; 85(6):1454-60. PubMed ID: 24429408
[TBL] [Abstract][Full Text] [Related]
32. Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.
Hamilton SN; Tyldesley S; Hamm J; Jiang WN; Keyes M; Pickles T; Lapointe V; Kahnamelli A; McKenzie M; Miller S; Morris WJ
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):934-41. PubMed ID: 25240272
[TBL] [Abstract][Full Text] [Related]
33. Polycystic kidney disease and cancer after renal transplantation.
Wetmore JB; Calvet JP; Yu AS; Lynch CF; Wang CJ; Kasiske BL; Engels EA
J Am Soc Nephrol; 2014 Oct; 25(10):2335-41. PubMed ID: 24854270
[TBL] [Abstract][Full Text] [Related]
34. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis.
Yamada A; Komaki Y; Komaki F; Micic D; Zullow S; Sakuraba A
Lancet Oncol; 2018 Jun; 19(6):758-767. PubMed ID: 29706374
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of genital dysplasia after kidney transplantation--a retrospective, non-interventional study from two centers.
Marschalek J; Helmy S; Schmidt A; Polterauer S; Sobulska M; Gyoeri GP; Grimm C
Acta Obstet Gynecol Scand; 2015 Aug; 94(8):891-7. PubMed ID: 25912178
[TBL] [Abstract][Full Text] [Related]
36. Cancer incidence in a kidney-transplanted population.
Kyllönen L; Salmela K; Pukkala E
Transpl Int; 2000; 13 Suppl 1():S394-8. PubMed ID: 11112040
[TBL] [Abstract][Full Text] [Related]
37. Favorable graft survival in renal transplant recipients with polycystic kidney disease.
Johnston O; O'Kelly P; Donohue J; Walshe JJ; Little DM; Hickey D; Conlon PJ
Ren Fail; 2005; 27(3):309-14. PubMed ID: 15957548
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for development of new-onset diabetes mellitus in pediatric renal transplant recipients: an analysis of the OPTN/UNOS database.
Kuo HT; Poommipanit N; Sampaio M; Reddy P; Cho YW; Bunnapradist S
Transplantation; 2010 Feb; 89(4):434-9. PubMed ID: 20177345
[TBL] [Abstract][Full Text] [Related]
39. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
40. Native nephrectomy for autosomal dominant polycystic kidney disease: before or after kidney transplantation?
Kirkman MA; van Dellen D; Mehra S; Campbell BA; Tavakoli A; Pararajasingam R; Parrott NR; Riad HN; McWilliam L; Augustine T
BJU Int; 2011 Aug; 108(4):590-4. PubMed ID: 21166760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
